This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Novo Nordisk A/s. Active years: 2018.
Company Filing History:
Years Active: 2018
Title: Gustav Roeder: Innovator in Antibody Research
Introduction
Gustav Roeder is a notable inventor based in Frederikssund, Denmark. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies that target specific proteins involved in various biological processes.
Latest Patents
Gustav Roeder holds a patent for "Antibodies that bind urokinase plasminogen activator." This invention relates to a method of identifying urokinase plasminogen activator (uPA) antibodies. The patent also covers antibodies capable of binding uPA and reducing or inhibiting its activity. Furthermore, the invention outlines therapeutic and pharmaceutical uses for such antibodies.
Career Highlights
Roeder is currently employed at Novo Nordisk A/S, a leading global healthcare company. His work focuses on innovative solutions in the field of biopharmaceuticals, contributing to advancements in medical treatments.
Collaborations
Some of his notable coworkers include Jesper Pass and Soeren Padkjaer, who collaborate with him on various projects within the company.
Conclusion
Gustav Roeder's work in antibody research exemplifies the innovative spirit of modern biotechnology. His contributions have the potential to impact therapeutic applications significantly.